Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Tools That Predict and Stage Mild Cognitive Impairment

NCT07516119 is registered in ClinicalTrials.gov with Prevention Research Consortium Corp. as lead sponsor.

NCT NCT07516119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07516119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Tools That Predict and Stage Mild Cognitive Impairment
Lead sponsor
Prevention Research Consortium Corp.
Phase
Observational
Overall status
Recruiting
Start date
November 15, 2026
Completion date
April 15, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia (ad), alzheimer disease (ad), apoe-4 positive, mild cognitive impairment (mci)